Literature DB >> 3354409

Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy.

T De Marco1, K Chatterjee, J L Rouleau, W W Parmley.   

Abstract

Coronary sinus blood flow, transmyocardial oxygen extraction, myocardial oxygen consumption, and transmyocardial lactate extraction were determined, along with systemic hemodynamics, in 34 patients with chronic stable angina without heart failure (group 1), in 66 patients with heart failure associated with coronary artery disease (group 2), and in 28 patients with heart failure caused by dilated cardiomyopathy without coronary artery disease (group 3). Compared with group 1 patients, in patients with heart failure in groups 2 and 3, resting coronary sinus blood flow was 30% and 24% higher, respectively (p less than 0.05), myocardial oxygen consumption was 25% higher (p less than 0.01), and coronary sinus oxygen content was 33% lower (p less than 0.01). The rate-pressure product was not different between the three groups. In eight patients with heart failure (five in group 2 and three in group 3), myocardial lactate production was observed without angina. Thus in patients with chronic heart failure resulting from either chronic coronary artery disease or dilated cardiomyopathy, resting coronary blood flow and myocardial oxygen consumption tend to increase probably because of an increase in myocardial oxygen requirements. Silent myocardial ischemia may also occur in both the presence and absence of coronary artery disease in patients with chronic heart failure. The abnormal coronary hemodynamics and myocardial metabolic function may play a role in causing progressive deterioration in cardiac function in dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3354409     DOI: 10.1016/0002-8703(88)90883-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

Review 1.  Inhibitors of the renin-angiotensin system in established cardiac failure.

Authors:  K Chatterjee
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 2.  The renin-angiotensin system and coronary vasomotion.

Authors:  G Ertl; K Hu; W R Bauer; B Bauer
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

3.  Myocardial oxidative metabolic supply-demand relationships in patients with nonischemic dilated cardiomyopathy.

Authors:  Marvin W Kronenberg; Gerald I Cohen; Marlo F Leonen; Thomas A Mladsi; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

Review 4.  Systemic and coronary haemodynamics and pharmacodynamics of enalapril and enalaprilat in congestive heart failure.

Authors:  K Chatterjee; T De Marco
Journal:  Drugs       Date:  1990       Impact factor: 9.546

5.  Endogenous plasma endothelin concentrations and coronary circulation in patients with mild dilated cardiomyopathy.

Authors:  M Mundhenke; B Schwartzkopff; M Köstering; U Deska; R M Klein; B E Strauer
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

6.  Significance of preoperative left ventricular ejection fraction in 5-year outcome after isolated CABG.

Authors:  Aida Fallahzadeh; Ali Sheikhy; Ali Ajam; Saeed Sadeghian; Mina Pashang; Mahmoud Shirzad; Jamshid Bagheri; Soheil Mansourian; Shahram Momtahen; Kaveh Hosseini
Journal:  J Cardiothorac Surg       Date:  2021-12-27       Impact factor: 1.637

7.  Treatment of Cheyne-Stokes Respiration in Heart Failure with Adaptive Servo-Ventilation: An Integrative Model.

Authors:  Wen-Hsin Hu; Michael C K Khoo
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

8.  Importance of oxygen-haemoglobin binding to oxygen transport in congestive heart failure.

Authors:  R M Bersin; M Kwasman; D Lau; C Klinski; K Tanaka; P Khorrami; T DeMarco; C Wolfe; K Chatterjee
Journal:  Br Heart J       Date:  1993-11

9.  Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.

Authors:  Eric J Velazquez; Kerry L Lee; Robert H Jones; Hussein R Al-Khalidi; James A Hill; Julio A Panza; Robert E Michler; Robert O Bonow; Torsten Doenst; Mark C Petrie; Jae K Oh; Lilin She; Vanessa L Moore; Patrice Desvigne-Nickens; George Sopko; Jean L Rouleau
Journal:  N Engl J Med       Date:  2016-04-03       Impact factor: 91.245

10.  Antifailure therapy including spironolactone improves left ventricular energy supply-demand relations in nonischemic dilated cardiomyopathy.

Authors:  Susan P Bell; Douglas W Adkisson; Mark A Lawson; Li Wang; Henry Ooi; Douglas B Sawyer; Marvin W Kronenberg
Journal:  J Am Heart Assoc       Date:  2014-08-27       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.